TD Cowen reiterated a Buy rating on Klaviyo on July 21, 2025.
4 reports, 2 independent
Updated Aug 10
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen reiterated a Buy rating on Klaviyo on July 21, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Citigroup and TD Cowen provided new analyst ratings and price targets for Klaviyo.1 source
TD Cowen reiterated a Buy rating on Klaviyo stock.1 source
Keep exploring
The entities involved
Related events
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- TD Cowen maintained a Buy rating on Forgent on September 15, 2026.
- TD Cowen provided analyst ratings and price targets for Ardelyx, accompanied by required stock transaction filings with the SEC.
- TD Cowen reiterated buy rating on Axis Capital, with coverage reported by Benzinga.
- TD Cowen upgraded Crescent Biopharma shares to 'strong-buy', while Wedbush reiterated 'outperform', and a CEO sold shares under a 10b5-1 plan.
Coverage
Newest first; wire copies grouped- themarketsdaily.com
- Insider MonkeyTD Cowen Reiterated a Buy Rating on Klaviyo (KVYO), Kept the PT Unchanged Klaviyo, Inc. (NYSE:KVYO) is one of the Most Promising New Technology Stocks According to Wall Street Analysts. On June 23, D